Optical Imaging, Ltd., is a revenue stage medical device company focused on clinical markets. It is currently addressing ophthalmic market needs by providing equipment for early diagnosis, targeted treatment and treatment monitoring. Its Retinal Function Imager (RFI) and Brain Imager 3001 systems are based on Optical Imaging's proprietary technological innovations which won world-wide recognition because of its unique ability to "see the invisible" TM. Using state-of-the-art image acquisition hardware, image processing, and statistical analysis algorithms, Optical Imaging, Ltd. is dedicated to developing and introducing to the medical community novel diagnostic equipment that supplement and will gradually replace the current gold standard.